<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> is a major contributor to the pathogenesis of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the peripheral immune response, caspase-1 activation involves the formation of a macromolecular complex termed the inflammasome </plain></SENT>
<SENT sid="2" pm="."><plain>We determined whether nucleotide-binding, leucine-rich repeat, pyrin domain containing 1 (NLRP1), molecular platform consisting of capase-1, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-associated speck-like protein containing a caspase-activating recruitment domain (ASC), and NLRP1, is expressed in the <z:mpath ids='MPATH_458'>normal</z:mpath> and postischemic brain </plain></SENT>
<SENT sid="3" pm="."><plain>Mice underwent <z:hpo ids='HP_0001727'>thromboembolic stroke</z:hpo> to investigate the formation of the inflammasome and subsequent activation of downstream <z:mp ids='MP_0001845'>inflammatory responses</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Western blot analysis showed expression and activation of interleukin (IL) IL-1beta and IL-18 at 24 h after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Size-exclusion chromatography and coimmunoprecipitation analysis showed protein association between NLRP1, ASC, caspase-1, and the <z:hpo ids='HP_0001417'>X-linked</z:hpo> inhibitor of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> protein (XIAP) </plain></SENT>
<SENT sid="6" pm="."><plain>After <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, immunohistochemical analysis revealed inflammasome proteins in neurons, astrocytes, and microglia/macrophages </plain></SENT>
<SENT sid="7" pm="."><plain>The potential of the inflammasome as an antiinflammatory target was showed by interference of inflammasome activation resulting in reduced cytokine levels in mice treated after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> with a neutralizing antibody against NLRP1 </plain></SENT>
<SENT sid="8" pm="."><plain>These findings show that the inflammasome complex forms after focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> and may be a novel therapeutic target for reducing the detrimental consequences of postischemic <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>